Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
Location: Flower Mound TX, Philadelphia PA, Seattle WA
Sponsor: CSL Behring
Sex: All
Age: 2 - 17
Code: NCT03684018
Recruiting
Community Opioid Innovation Network (JCOIN): TCU Clinical Research Center
for
Addiction, Opioid
Location: Fort Worth TX
Sponsor: Texas Christian University
Sex: All
Age: 18+
Code: NCT04276792
Recruiting
Strength Training Augmenting Rehabilitation
for
Muscle Disuse Atrophy
Location: Fort Worth TX
Sponsor: Texas Christian University
Sex: All
Age: 18 - 35
Code: NCT05097092
Recruiting
Targeting Endoplasmic Reticulum Stress in Human Hypertension
for
Hypertension
Location: Fort Worth TX
Sponsor: University of North Texas Health Science Center
Sex: All
Age: 18 - 70+
Code: NCT06025630
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
SHE Tribe: An Intervention to Improve Health Behavior Among Women in Underserved Communities
for
Health Promotion
Location: Fort Worth TX
Sponsor: University of North Texas Health Science Center
Sex: Female
Age: 18+
Code: NCT03463213
Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
for
CKD, Metabolic Acidosis
Location: Fort Worth TX, Houston TX, San Antonio TX, Van Vleck TX,
Sponsor: Renibus Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07355062
Phase 3, Recruiting
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
for
ER-Positive HER2-Negative Breast Cancer
Location: Fort Worth TX, Kingwood TX, Marietta GA, Edgewood KY
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07647328
Phase 3, Recruiting
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
for
Renal Insufficiency, Chronic
Location: Fort Worth TX, Stephenville TX, Sugar Land TX,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07624305
Phase 3, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Fort Worth TX, Round Rock TX, Shreveport LA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase 3, Recruiting
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
for
Asthma
Location: McKinney TX, Kansas City KS, St Louis MO, Maryville IL,
Sponsor: Enveda Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07301255
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
for
Schizophrenia
Location: Garland TX, Houston TX, Atlanta GA, Stone Mountain GA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 13 - 17
Code: NCT07288567
Phase 3, Recruiting
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
for
Schizophrenia, Autism-Related Irritability
Location: Garland TX, Houston TX, Atlanta GA, Stone Mountain GA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 5 - 17
Code: NCT07424404
Phase 3, Recruiting
Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
for
Transthyretin (TTR) Amyloid Cardiomyopathy
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 30 - 70+
Code: NCT07196839
Recruiting
Trifecta-Heart cfDNA-MMDx Study
for
Heart Transplant Rejection
Location: Dallas TX, Little Rock AR, Tampa FL, Salt Lake City UT,
Sponsor: University of Alberta
Sex: All
Age: 0+
Code: NCT04707872
Recruiting
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
for
Ovarian Cancer
Location: Fort Worth TX, Orlando FL, Fountain Valley CA,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT07546500
Phase 3, Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Fort Worth TX, Oklahoma City OK, Nashville TN,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701682
Phase 2, Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Fort Worth TX, Oklahoma City OK, Nashville TN,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06703073
Phase 2, Recruiting
A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
for
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
Location: Fort Worth TX, Orlando FL, Fountain Valley CA,